Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.
Sotomi Y, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigator. Sotomi Y, et al. Among authors: sato t. Heart. 2023 Jul 27;109(16):1231-1240. doi: 10.1136/heartjnl-2022-322181. Heart. 2023. PMID: 36822821 Free PMC article.
Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function.
Oeun B, Hikoso S, Nakatani D, Mizuno H, Kitamura T, Okada K, Dohi T, Sotomi Y, Kida H, Sunaga A, Sato T, Matsuoka Y, Kurakami H, Yamada T, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure Investigators. Oeun B, et al. Among authors: sato t. Clin Res Cardiol. 2023 Jan;112(1):145-157. doi: 10.1007/s00392-022-02121-z. Epub 2022 Nov 10. Clin Res Cardiol. 2023. PMID: 36357804
Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
Sotomi Y, Tamaki S, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Sakamoto D, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigators. Sotomi Y, et al. Among authors: sato t. Heart. 2024 Feb 23;110(6):441-447. doi: 10.1136/heartjnl-2023-323059. Heart. 2024. PMID: 37827559
β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.
Hikoso S, Kida H, Sunaga A, Nakatani D, Okada K, Dohi T, Sotomi Y, Oeun B, Sato T, Matsuoka Y, Kitamura T, Yamada T, Kurakami H, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure investigators. Hikoso S, et al. Among authors: sato t. Clin Res Cardiol. 2024 Jun;113(6):842-855. doi: 10.1007/s00392-023-02301-5. Epub 2023 Nov 29. Clin Res Cardiol. 2024. PMID: 38019285
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction.
Iwakura K, Onishi T, Okamura A, Koyama Y, Tanaka N, Okada M, Fujii K, Seo M, Yamada T, Yano M, Hayashi T, Yasumura Y, Nakagawa Y, Tamaki S, Nakagawa A, Sotomi Y, Hikoso S, Nakatani D, Sakata Y; PURSUIT-HFpEF Investigators. Iwakura K, et al. Sci Rep. 2024 Jan 19;14(1):1746. doi: 10.1038/s41598-024-52101-8. Sci Rep. 2024. PMID: 38243047 Free PMC article.
Uplift modeling to identify patients who require extensive catheter ablation procedures among patients with persistent atrial fibrillation.
Sato T, Sotomi Y, Hikoso S, Kitamura T, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Matsuoka Y, Tanaka N, Watanabe T, Makino N, Egami Y, Oka T, Minamiguchi H, Miyoshi M, Okada M, Kanda T, Matsuda Y, Kawasaki M, Masuda M, Inoue K, Sakata Y; OCVC-Arrhythmia Investigators. Sato T, et al. Sci Rep. 2024 Feb 1;14(1):2634. doi: 10.1038/s41598-024-52976-7. Sci Rep. 2024. PMID: 38302547 Free PMC article.
Duration of atrial fibrillation persistence: implications for recurrence risk after catheter ablation and efficacy of additional substrate ablation.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Makino N, Egami Y, Oka T, Minamiguchi H, Miyoshi M, Okada M, Kanda T, Matsuda Y, Kawasaki M, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Tsuda M, Okamoto N, Yano M, Nishino M, Sunaga A, Sotomi Y, Dohi T, Nakatani D, Hikoso S, Sakata Y; Osaka Cardiovascular Conference (OCVC)–Arrhythmia Investigators. Matsunaga-Lee Y, et al. Heart Rhythm. 2024 Feb 1:S1547-5271(24)00107-3. doi: 10.1016/j.hrthm.2024.01.053. Online ahead of print. Heart Rhythm. 2024. PMID: 38307310
Individual acute-phase bleeding and thrombotic risk balance assessment in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
Sotomi Y, Hikoso S, Komukai S, Kitamura T, Nakatani D, Dohi T, Mizuno H, Okada K, Kida H, Oeun B, Sunaga A, Sato T, Matsuoka Y, Sakata Y, Sato H, Hori M, Komuro I, Sakata Y; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Sotomi Y, et al. Among authors: sato t, sato h. Am Heart J Plus. 2023 Mar 17;28:100292. doi: 10.1016/j.ahjo.2023.100292. eCollection 2023 Apr. Am Heart J Plus. 2023. PMID: 38511074 Free PMC article.
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study.
Okada M, Inoue K, Tanaka N, Tanaka K, Hirao Y, Iwakura K, Egami Y, Masuda M, Watanabe T, Minamiguchi H, Oka T, Hikoso S, Sunaga A, Okada K, Nakatani D, Sotomi Y, Sakata Y; Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators. Okada M, et al. Europace. 2024 May 2;26(5):euae120. doi: 10.1093/europace/euae120. Europace. 2024. PMID: 38691672 Free PMC article.
16,730 results
You have reached the last available page of results. Please see the User Guide for more information.